Harbor Investment Advisory’s Takeda Pharmaceutical TAK Stock Holding History

Harbor Investment Advisory’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24	Closed	-$333	–	1438
2024 Q1	$333	Buy	+24	New	+$349	﹤0.01%	1271

Other funds holding TAK

GAM

Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Harbor Investment Advisory's TAK Position: Q2 2024 in Review

Harbor Investment Advisory sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 24 shares — an estimated $333 sold.

Harbor Investment Advisory first reported a position in TAK in Q1 2024 and held it in 1 quarter. The position peaked at $333 in Q1 2024. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

Harbor Investment Advisory reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Harbor Investment Advisory sold 24 Takeda Pharmaceutical shares in Q2 2024, an estimated $333.
Harbor Investment Advisory first reported a position in Takeda Pharmaceutical in Q1 2024 and held it in 1 quarter.
Harbor Investment Advisory's Takeda Pharmaceutical position peaked at $333 in Q1 2024.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Harbor Investment Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.